BioCryst Upgrade Almost Looks Misunderstood
The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals may be very misunderstood for what it is.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 267Genetic Technologies Drives Ahead in the Fight Against Cancer
ThinkstockGenetic Technologies Limited (NASDAQ: GENE) has been making large strides in the area of women’s health recently with the opening of more centers that utilize the BREVAGenplus. Ultimately this will benefit women who are…
Is Ampio at Risk of Imploding?
Ampio announced Monday that a Phase 3 for the treatment pain due to osteoarthritis of the knee did not reach its primary endpoint against a saline control.
Is GW Pharmaceuticals the Perfect Cannabis Stock on National Weed Day?
GW Pharmaceuticals shares were actually unexciting on Monday, National Weed Day.
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
In a new report, Cowen analysts have sights set on three major pharmaceutical stocks that they expect to have rising first-quarter earnings.
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
247 Wall St. could not help but notice four analyst calls this past week in which upside of 50% to 100% was predicted for four biotech and specialty pharma stocks.
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight.
Akebia Hits New Low After Pricing Secondary Offering
Akebia Therapeutics shares hit a new 52-week low after the company announced the pricing for its secondary offering.
Are Billions About to Be Made in Cosmetic Dermatology by 3 Companies?
While few people may want to admit it, but more and more cosmetic surgery and treatments are being done every year. The sales potential is in the billions.
Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks
On the close Friday, the NYSE Arca Biotechnology Index is set for a rebalance. These four stocks that could see the highest amount of share count buying.
UnitedHealth Makes a Push With Earnings
UnitedHealth Group reported better-than-expected first-quarter financial results Thursday before the markets opened.
Johnson & Johnson Slices Forecast as Strong Dollar Hits Revenues
Johnson & Johnson reported better-than-expected first-quarter fiscal 2015 results before markets opened Tuesday morning.
Can a Small New Stem Cell Pact Move the Needle for Celgene?
Celgene is one of the world's top biotech stocks now, and its market cap is nearly $100 billion. The company has made a new investment in a stem cell company in Australia.
Short Sellers Increase Their Bets Against Biotech Stocks
The March 31 short interest data have been compared with the March 13 figures, and for most of the selected biotech stocks, short interest has increased.
Why Mylan Still Has Upside After Perrigo
Independent research firm Argus has weighed in on Mylan and Perrigo prior to the acquisition.